Denka Company (4061) Q4 2025 earnings summary

Executive summary

• FY2024 operating income increased to 14.4 billion yen (+1.0 billion yen YoY), but net income dropped to -12.3 billion yen due to a 16.1 billion yen impairment loss at Denka Performance Elastomer (DPE) and other extraordinary losses.

• DPE's U.S. chloroprene rubber production was suspended indefinitely, with all options including sale under consideration; supply to customers will shift to the Omi Plant.

• Comprehensive income turned negative at -7.1 billion yen, compared to 19.3 billion yen last year.

• FY2025/FY2026 is forecasted to deliver a V-shaped recovery, with operating income expected to rise to 25.0 billion yen (+10.6 billion yen YoY) and net income to 15.0 billion yen (+27.3 billion yen YoY), supported by extraordinary gains offsetting potential further losses.

Financial highlights

• FY2024 sales rose to 400.3 billion yen (+11.0 billion yen YoY), but missed the November forecast by 19.7 billion yen.

• Operating margin improved slightly to 3.6% (+0.2pp YoY); ordinary income increased to 7.6 billion yen (+2.1 billion yen YoY).

• Major extraordinary losses included DPE impairment (-16.1 billion yen) and business liquidation (-7.9 billion yen).

• Cash and cash equivalents at year-end were 37.0 billion yen, up 1.6 billion yen YoY.

• FY2025/FY2026 forecasts sales of 410.0 billion yen, operating margin of 6.1%, and ordinary income of 19.0 billion yen.

Outlook and guidance

• FY2025/FY2026 expects a significant profit rebound, driven by improved profitability in the chloroprene rubber business, cost reductions, and recovery in electronics and innovative products.

• Dividend forecast maintained at 100 yen/share, with a total return ratio target of 50%.

• Management plan revision and performance recovery measures to be announced by end of FY2025.

• Demand expected to recover in the second half, especially in Electronics & Innovative Products.